A Doctor of Pharmacy, or PharmD, is the professional doctoral degree required to practice as a licensed pharmacist in the United States. It’s a six-year program (two years of prerequisites plus four years of professional coursework) that trains graduates to manage medications, advise patients, and work alongside physicians and nurses as part of a healthcare team. Since 2000, the PharmD has been the only accredited pharmacy degree in the U.S., replacing the older Bachelor of Pharmacy.
How the PharmD Replaced the Bachelor’s Degree
For most of the 20th century, pharmacists earned a Bachelor of Pharmacy (BPharm), a five-year degree focused heavily on dispensing medications. The debate over upgrading to a doctoral-level program started as early as 1948, when the American Council on Education recommended a six-year curriculum. Progress was slow. As late as 1989, 56% of U.S. pharmacy schools still offered only the bachelor’s degree.
The turning point came in 1992, when delegates from the profession voted overwhelmingly to endorse the PharmD as the sole entry-level degree. By 1997, the accrediting body announced it would stop accrediting BPharm programs, and all schools had to complete the transition by 2000. The reason was straightforward: the knowledge base of pharmacy had expanded dramatically, and pharmacists needed deeper training in patient care, drug therapy, and clinical decision-making to keep up.
The practical difference between the two degrees is about a year of additional coursework focused on pharmacotherapy (how drugs treat specific diseases) and significantly more hands-on clinical training. Pharmacists who earned a BPharm before the transition are still licensed and practicing, but every new graduate since 2000 holds a PharmD.
What the Six-Year Program Looks Like
The first two years are pre-professional prerequisites, typically completed at an undergraduate university. These cover biology, general and organic chemistry, calculus, statistics, and English composition, totaling roughly 60 to 62 credits. Some students complete these as part of a bachelor’s degree in another field before applying to pharmacy school; others enter directly from a pre-pharmacy track.
The four professional years follow a specific arc. Years one and two build foundational knowledge: anatomy and physiology, biochemistry, how drugs work in the body, and how drug formulations are designed and delivered. By the second year, students start studying drug therapy organized by disease, covering cardiovascular disease, infectious diseases, gastrointestinal conditions, and endocrine disorders like diabetes. They also learn to evaluate published drug research and practice patient counseling skills.
Year three gets more specialized, with coursework in oncology, neurology, psychiatry, critical care, pulmonology, immunology, and pharmacy law. Students also study population health management and the economics of medication use. Throughout these three years, case conferences require students to apply what they’ve learned to realistic patient scenarios.
The fourth year is almost entirely clinical rotations. Students complete a series of advanced practice experiences in hospitals, community pharmacies, clinics, and specialty settings, working directly with patients and healthcare teams under supervision. This final year is what distinguishes the PharmD most sharply from the old bachelor’s program.
Licensing After Graduation
Earning the PharmD doesn’t automatically make someone a licensed pharmacist. Graduates must pass two national exams: the NAPLEX, which tests pharmacy knowledge and clinical judgment, and the MPJE, which tests knowledge of federal and state pharmacy law. Both are required before a state board of pharmacy will issue a license. Pharmacy schools also verify that graduates have completed the required number of supervised intern hours during the program.
What Pharmacists Actually Do
The public image of a pharmacist is someone behind a counter filling prescriptions, but the PharmD trains graduates for a much broader clinical role. In hospitals, pharmacists review drug orders, check for dangerous interactions, calculate doses based on a patient’s weight or kidney function, and recommend changes to a patient’s medication plan. In cancer care, for instance, pharmacists calculate chemotherapy doses based on body surface area, a task where precision is critical and errors can be life-threatening.
Hospital pharmacists also participate in ward rounds with physicians and nurses, answering drug-related questions in real time rather than being consulted after the fact. They lead medication reconciliation, the process of comparing what a patient was taking before admission with what they’re prescribed in the hospital and at discharge, to catch errors and gaps. They develop and update protocols for how specific drugs should be dosed, monitored, and administered.
In community and outpatient settings, pharmacists provide medication therapy management: sitting down with patients (often those on many medications) to review their full drug regimen, identify problems like duplicate therapies or missed doses, and coordinate with prescribers to make changes. Many states also authorize pharmacists to administer vaccines, prescribe certain medications like birth control or smoking cessation aids, and manage chronic conditions like diabetes or high blood pressure under collaborative practice agreements with physicians.
Collaborative Practice Agreements
These agreements are expanding pharmacists’ scope in many states. Under a collaborative practice agreement, a pharmacist works with a supervising physician who delegates specific clinical tasks, such as adjusting medication doses, ordering lab tests, or substituting biosimilar drugs. The specifics vary by state. North Carolina, for example, is currently considering legislation that would allow clinical pharmacist practitioners to perform a wider range of medical acts under physician supervision, as long as the arrangement is documented in a written, site-specific agreement.
Post-Graduate Training and Specialization
Many PharmD graduates pursue additional training beyond the degree. A PGY1 (post-graduate year one) residency is a one-year program that provides broad clinical experience across multiple disease areas and patient populations. It’s the standard path for pharmacists who want to work in hospitals or clinical settings rather than community retail. A PGY2 residency adds another year of focused training in a specific area, such as infectious diseases, critical care, or oncology, and prepares pharmacists to become specialists.
For those drawn to research rather than direct patient care, clinical research fellowships are typically two-year programs that train pharmacists to design studies, analyze data, write grants, and publish findings. Fellowship graduates often pursue academic or industry research careers.
The Board of Pharmacy Specialties recognizes 15 specialty areas, including ambulatory care, cardiology, critical care, emergency medicine, geriatrics, infectious diseases, oncology, pediatrics, psychiatry, and solid organ transplantation. Board certification in any of these requires passing an additional exam and demonstrates advanced expertise.
Career Paths and Salary
Pharmacy careers span more than 100 pathways. The most common are community (retail) pharmacy and hospital pharmacy, but PharmD holders also work in the pharmaceutical industry managing drug development, clinical trials, and safety monitoring. Nuclear pharmacists prepare and manage radioactive drugs used in diagnostic imaging and cancer treatment. Others work in veterinary pharmacy, public health, regulatory affairs, or academia.
The median annual salary for pharmacists was $137,480 in 2024, according to the Bureau of Labor Statistics. Employment is projected to grow 5% from 2024 to 2034, which is faster than the average for all occupations. Growth is being driven partly by an aging population needing more medication management and partly by the expanding clinical role pharmacists play in healthcare teams.
The Push for Federal Provider Status
One major policy issue for the profession is whether pharmacists should be recognized as healthcare providers under Medicare. Currently, pharmacists can provide many clinical services but often can’t bill Medicare directly for them, which limits access especially in rural and underserved areas. The Pharmacy and Medically Underserved Areas Enhancement Act, introduced in Congress, would amend the Social Security Act to add “pharmacist services” to the list of covered Medicare services. The bill has been introduced in multiple sessions but has not yet been signed into law. If passed, it would allow pharmacists to be reimbursed for the patient care services they’re already trained and licensed to provide.